Skyrizi 150 MG/ML penml
Ended Awarded Last action
- Contract number
- SPE2DR26F4G0G
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $81,507
Award facts
- Contract value 100% obligated
- $81,506.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $81,506.80 to AmerisourceBergen Drug Corp for the supply of SKYRIZI 150 mg/ml pen/ml, a pharmaceutical product for federal medical procurement needs. This firm fixed-price delivery order, issued on January 28, 2026, with an ultimate completion date of January 29, 2026, represents a competitive award with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc., a major pharmaceutical distributor serving as the parent organization and prime contractor for the Defense Logistics Agency's comprehensive medical supply contracts.
This delivery order is executed under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026, which serves as a global pharmaceutical support vehicle. The IDC enables the company to supply a comprehensive range of pharmaceutical products, specialty medications, generic and brand-name drugs, vaccines, and medical supplies to support military healthcare programs worldwide, including services to the Defense Health Agency, U.S. Coast Guard, and other federal government healthcare systems. The competitive award demonstrates AmerisourceBergen's established capability to efficiently fulfill federal pharmaceutical procurement requirements through this flexible contract structure.
Quick answers
Who was awarded contract SPE2DR26F4G0G?
SPE2DR26F4G0G was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26F4G0G worth?
The government has obligated $81,507 on SPE2DR26F4G0G.
Is contract SPE2DR26F4G0G an order under another contract?
Yes. SPE2DR26F4G0G is a delivery order under SPE2DR25D3012, an indefinite delivery contract.
Was contract SPE2DR26F4G0G competed?
The extent of competition for SPE2DR26F4G0G was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award